Hochschulschrift
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains=Onkolytische Virotherapie und Modulation des Tumormilieus mittels verschiedener Vaccinia-Virus-Typen
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
128 S.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Würzburg, Univ., Diss., 2014
- Klassifikation
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Schlagwort
-
Onkolyse
Vaccinia-Virus
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 14:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Antigene des Vaccinia Virus
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Antigene des Vaccinia Virus
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2
Immune checkpoint modulation enhances oncolytic virotherapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Starvation-Induced Differential Virotherapy Using an Oncolytic Measles Vaccine and Vaccinia Virus
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Vaccinia virus-encoded bacterial beta-glucuronidase as a diagnostic biomarker for oncolytic virotherapy
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Targeting hematologic malignancies with oncolytic vaccinia virus constructs
Oncolytic Virotherapy of Neuroendocrine Neoplasms with the Vaccinia virus GLV-1h68 and the Herpes simplex virus T-VEC
Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody
Antigene des Vaccinia Virus
Antitumor activity of recombinant oncolytic vaccinia virus with human IL2